WuXi Biologics Cayman Inc., one of China’s leading drug contract research and manufacturing companies, said its chief executive officer has not worked for any military-affiliated institution. The stock was hammered in Hong Kong on Friday following the news that proposed US legislation would ban the company from American government contracts. Sangmi Cha reports on Bloomberg Television.
——–
Follow Bloomberg for business news & analysis, up-to-the-minute market data, features, profiles and more:
Connect with us on…
Twitter:
Facebook:
Instagram:
source